Device Closure of Patent Foramen Ovale Versus Medical Therapy in Cryptogenic Stroke
- 1 December 2013
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 6 (12), 1316-1323
- https://doi.org/10.1016/j.jcin.2013.08.001
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Critique of Closure or Medical Therapy for Cryptogenic Stroke With Patent Foramen OvaleStroke, 2012
- Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke PreventionStroke, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic strokeTrials, 2011
- Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic strokeJournal of the American College of Cardiology, 2004
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or BothNew England Journal of Medicine, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996